ArticleBioengineering (Basel, Switzerland)2025
Enhanced Blood Cell Detection in YOLOv11n Using Gradient Accumulation and Loss Reweighting.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Automated blood cell detection is of significant importance in the efficient and accurate diagnosis of hematological diseases. The application of this technology has advanced clinical practice in hematology and improved the speed and accuracy of diagnosis, thereby providing patients with more timely medical intervention. In this study, the YOLOv11n model was optimized by integrating gradient accumulation and loss reweighting techniques to improve its detection performance for blood cells in clinical images. The optimized YOLOv11n model shows an improvement in performance. The mAP50 reached 0.9356, the mAP50-95 was 0.6620, and the precision and recall were better than those of existing methods. The model can effectively address issues such as dense cell distribution, cell overlap, and image artifacts. Therefore, it is highly applicable in real-time clinical applications. The results of the ablation experiment demonstrate that there is a synergistic effect between gradient accumulation and loss reweighting, which can improve detection accuracy without increasing the computational burden. The conclusion indicates that the optimized YOLOv11n model has important application prospects as an automated blood cell detection tool and has the potential to integrate with clinical workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.